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Prokineticin Receptor-1 Is a New Regulator of Endothelial Insulin
Uptake and Capillary Formation to Control Insulin Sensitivity and
Cardiovascular and Kidney Functions
Mojdeh Dormishian, PhD;* Gulen Turkeri, MD;* Kyoji Urayama, PharmD, PhD; Thu Lan Nguyen, MSc; Mounia Boulberdaa, PhD;
Nadia Messaddeq, PhD; Gilles Renault, PhD; Daniel Henrion, PhD; Canan G. Nebigil, PharmD, PhD
Background-—Reciprocal relationships between endothelial dysfunction and insulin resistance result in a vicious cycle of
cardiovascular, renal, and metabolic disorders. The mechanisms underlying these impairments are unclear. The peptide hormones
prokineticins exert their angiogenic function via prokineticin receptor-1 (PKR1). We explored the extent to which endothelial PKR1
contributes to expansion of capillary network and the transcapillary passage of insulin into the heart, kidney, and adipose tissues,
regulating organ functions and metabolism in a speciﬁc mice model.
Methods and Results-—By combining cellular studies and studies in endothelium-speciﬁc loss-of-function mouse model (ec-
PKR1/), we showed that a genetically induced PKR1 loss in the endothelial cells causes the impaired capillary formation and
transendothelial insulin delivery, leading to insulin resistance and cardiovascular and renal disorders. Impaired insulin delivery in
endothelial cells accompanied with defective expression and activation of endothelial nitric oxide synthase in the ec-PKR1/
aorta, consequently diminishing endothelium-dependent relaxation. Despite having a lean body phenotype, ec-PKR1/ mice
exhibited polyphagia, polydipsia, polyurinemia, and hyperinsulinemia, which are reminiscent of human lipodystrophy. High plasma
free fatty acid levels and low leptin levels further contribute to the development of insulin resistance at the later age. Peripheral
insulin resistance and ectopic lipid accumulation in mutant skeletal muscle, heart, and kidneys were accompanied by impaired
insulin-mediated Akt signaling in these organs. The ec-PKR1/ mice displayed myocardial ﬁbrosis, low levels of capillary
formation, and high rates of apoptosis, leading to diastolic dysfunction. Compact ﬁbrotic glomeruli and high levels of phosphate
excretion were found in mutant kidneys. PKR1 restoration in ec-PKR1/ mice reversed the decrease in capillary recruitment and
insulin uptake and improved heart and kidney function and insulin resistance.
Conclusions-—We show a novel role for endothelial PKR1 signaling in cardiac, renal, and metabolic functions by regulating
transendothelial insulin uptake and endothelial cell proliferation. Targeting endothelial PKR1 may serve as a therapeutic strategy
for ameliorating these disorders. ( J Am Heart Assoc. 2013;2:e000411 doi: 10.1161/JAHA.113.000411)
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E ndothelial dysfunction is a hallmark of cardiovasculardisorders characterized by inadequate vasodilatation
and/or paradoxical vasoconstriction of the coronary and
peripheral arteries.1 Endothelial dysfunction also contributes
to the impairment of insulin function by altering the
transcapillary passage of insulin to target tissues.2 Lower
levels of capillary network expansion, with an attenuation of
microcirculatory blood ﬂow to metabolically active tissues,
contribute to the impairment of insulin-stimulated glucose and
lipid metabolism.3 Therapeutic interventions improving endo-
thelial function have been shown to decrease metabolic and
cardiovascular abnormalities in animal4 and clinical investi-
gations.5 The identiﬁcation of endothelial factors linking
cardiovascular and metabolic disorders is therefore important
to understand the pathogenesis of metabolic syndrome.
Prokineticins are potent angiogenic factors. Prokineticins
1 and 2 are widely distributed in mammalian tissues6 and
human blood cells.7 They act as survival/mitogenic factors
in various cell types, including endothelial cells (ECs),8
neuronal cells,9 lymphocytes, hematopoietic stem cells,10
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and cardiomyocytes.11 They exert their biological effects
by stimulating 2 closely related receptors, prokineticin
receptor-1 (PKR1) and PKR2.12,13 Both receptors use several
G protein–signaling pathways and are ubiquitously expressed
in mammalian tissues.12–14 A different role of prokineticin-
2 has recently been described in ECs: the activation of PKR1
signaling promotes angiogenesis, and the activation of PKR2
induces fenestration in cardiac ECs.15 Moreover, the 2
receptors may have different expression proﬁles. For exam-
ple, human aortic ECs express only PKR1, and human hepatic
sinusoidal ECs express only PKR2. However, the extents to
which endothelial prokineticin signals affect heart, kidney,
and adipose functions and the contribution of angiogenesis
and insulin uptake to particular diseases have yet to be
investigated.
The objectives of the present study were to determine the
role of the endothelial PKR1 in cardiovascular, renal, and
metabolic hemostasis with particular emphasis on endothelial
proliferation as a ﬁrst step of angiogenesis and transcapillary
insulin transport. We generated a vascular EC-speciﬁc PKR1
knockout mouse (ec-PKR1/) with the Cre-loxP system and
demonstrated how PKR1 loss leads metabolic, cardiovascular,
and renal disorders. Our data support the emerging concepts
that the endothelium is a useful potential target for
treatments to combat insulin resistance, diabetes, and
cardiovascular diseases.
Methods
Generation of ec-PKR1/
The ec-PKR1/ were generated using the Cre-loxP system.
Mice harboring a PKR1 gene ﬂanked by loxP sites (PKR1lox/lox)
were bred with transgenic mice expressing the Cre recom-
binase under control of the tie2 promoter-enhancer. The
latter mice (B6.Cg-TgTie2-Cre 12F1v/J) were purchased from
the Jackson Laboratories. Earlier studies on tie2-cre trans-
genic mice have shown that tie2 expression is limited to
vascular ECs and endocardial cushions.16 Note that PKR1 is
not expressed in the endocardial cushions.11 As a result of
this breeding, all mice in these experiments have a C57Bl/6
genetic background. PKR1lox/lox mice, in which exon 2 of the
PKR1 gene is ﬂanked by loxP sites, have been previously
described.17 In the progeny of this cross, all mice have a
tie2-Cre:PKR1lox/WT genotype. The resulting mice were bred
with PKR1lox/lox mice to generate tie2-Cre:PKR1lox/lox mice
(named, for the sake of simplicity, ec-PKR1/ as they
harbor a homozygous deletion of PKR1 in ECs). Littermates
from the same breeding pairs PKR1lox/lox mice without tie2-
Cre transgene (L2/L2) were used as controls. Animals were
housed on a 12-hour light/dark cycle and were fed a
standard rodent chow. Note that the life span of the mutant
mice was reduced by 11%. All protocols for animal use,
surgery, and euthanasia were reviewed and approved by the
French Animal Care Committee and were in accordance with
European guidelines. All experiments were carried out in male
mice (150 mice) at the different ages (6, 12, 24, and
36 weeks).
Isolation and Culture of ECs
ECs were isolated by using a magnetic labeling procedure
using Dynabeads (Invitrogen) and a biotinylated antibody
against an EC surface antigen (the vascular endothelial growth
factor receptor FLK1; eBioscience), as described in the
manufacturer’s protocol.18 Mouse aorta, heart, kidney, and
adipose tissues were removed from control and ec-PKR1/
mice, cut into pieces (1 mm3) in buffer ([in mmol/L] NaCl
116, KCl 0.8, NaH2PO4 1, glucose 5.5, HEPES 20) containing
0.5 mg/mL collagenase type V and 1 mg/mL pancreatinine
and incubated for 45 minutes at 37°C. After digestion, ECs
were labeled with the Flk1 antibody and separated from the
remainder of the cells and debris through capture with
magnetic beads. ECs were then cultured in DMEM Glutamax
(Invitrogen) containing 4.5 g/L glucose and 20% fetal calf
serum, nonessential amino acids, 2 mmol/L glutamine,
10 lg/mL heparin, 100 lg/mL endothelial cell growth
supplements (ECGS) (Tebu-Bio). EC identity was conﬁrmed
by positive staining with a platelet-endothelial cell adhesion
molecule (PECAM-1) antibody (Santa Cruz Biotechnology).
Primary mouse cardiac glomerular ECs were also purchased
from Cellbiologics Inc and used up for to 3 passages. Bone
marrow cells were isolated from mice pelvic and femoral
bones as described (www.bi-protocol.org).
Cell proliferation and in vitro angiogenesis assays were
performed as previously described.15 Insulin uptake in ECs
in vitro19 and vivo20 was performed as described. ECs were
incubated with serum-free medium for 6 hour at 37°C,
followed by incubation with 100 nm/L FITC-insulin (Invitro-
gen) for the indicated time period (0 to 30 minutes) at 37°C.
Next, the cells were ﬁxed in methanol at 20°C for
10 minutes, and blocking of antigenic sites was performed
with PBS containing 10% donkey serum and 0.5% Triton X-
100 for 1 hour at room temperature. Cells were incubated
with the primary antibody (rabbit polyclonal anti-FITC, 1:100
dilution; Invitrogen) overnight at 4°C, and with a secondary
Alexa488-conjugated antibody for 1 hour at room tempera-
ture.19 Cells were washed and mounted with Vectashield
(Vector laboratories) containing DAPI and then analyzed by
ﬂuorescence microscopy. Fluorescence intensity of individual
cells reﬂecting FITC insulin uptake was quantiﬁed using the
National Institutes of Health ImageJ 1.37v software. At least
10 cells in 5 high-power microscopy ﬁelds (940) were
analyzed for each time point (0 to 30 minutes). For in vivo
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insulin uptake analysis, 100 mU/kg body weight FITC-insulin
was injected intravenously. Mice were killed 10 minutes
thereafter, and their tissues were collected and cryocon-
served. For the time zero point, after non–FITC-labeled insulin
injection, the mice were immediately killed and and their
tissues were collected and cryoconserved. Immunostaining
for FITC and PECAM-1 was performed on sectioned tissues.
Images were acquired at a resolution of 102491024 pixels
and stored in 24-bit tagged image format ﬁle format.
Fluorescence intensity of individual blood vessels reﬂecting
FITC-insulin uptake was quantiﬁed using ImageJ software. At
least 5 blood vessels in 5 high-power microscopy ﬁelds
(940) were analyzed.
Histological and Electron Microscopy Analyses
For histology, organs were removed from 3-, 12-, or 24-week-
old mice, dissected, and frozen for cryosectioning (5 lm), and
the sections were stained with Mallory tetrachrome. For
electron microscopy, all organs were ﬁxed by immersion in
glutaraldehyde, postﬁxed by incubation in osmium tetroxide,
and embedded in epoxy resin, using routine methods.11,21
Glomerular pathology analyses were based on the assess-
ment of 50 glomeruli analyzed on kidney cross sections.
Tubule damages (consisting of at least one of the following:
dilatation, atrophy, necrosis) were assessed by scoring 100
proximal tubules on kidney cross sections on randomly
chosen high-power microscopy ﬁelds (940).
Echocardiography and Blood Pressure
Assessment
Systolic function in 12- and 24-week-old male mice (n=6 for
each group) was assessed by echocardiography in M-mode
(Sonos 5500, Hewlett-Packard, with a 15-MHz linear trans-
ducer) and 2-dimensional measurements.21 We calculated
mean measurements for 6 selected cardiac cycles from at
least 2 independent scans performed in a randomized blind
fashion, with papillary muscles used as a point of reference to
ensure that all scans were carried out at the same level. Mean
systolic blood pressureand heart rate were obtained from tail
cuff measurements on 24-week-old mice by using the Visitech
System (Physiological Research Instruments).
Terminal Deoxynucleotidyl Transferase dUTP
Nick End Labeling Assay and
Immunohistochemistry
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assays were performed with an in situ cell death
detection kit (Roche), according to the manufacturer’s instruc-
tions.11 We acquired 6 to 10 images per sections (at least 10
sections) in organ (3 animals per genotype group, n=3) with
use of a ﬂuorescence microscope. The TUNEL labeling index
was calculated as the mean number of DAPI-stained TUNEL-
positive (i.e., it is the percentage of TUNEL-positive cells
among total [DAPI-labeled] cells) nuclei/glomerulus, for 50
glomeruli per kidney (n=3), or of DAPI-stained TUNEL-positive
nuclei in 10 high-power microscopic ﬁelds (940) per heart,
adipose tissue, or pancreatic sections (n=3), for the various
groups of mice. For immunoﬂuorescence staining of structural
proteins, frozen tissue sections were ﬁxed with 3.7% formal-
dehyde for 10 minutes, blocked, and stained with primary
antibodies against PECAM-1 (Santa Cruz), a–smooth muscle
actin (a-SMA) (Sigma), PKR1 (monoclonal antibody raised at
Institut de Genetique et de Biologie Moleculaire et Cellulaire,
Illkirch, France), PKR2 (Abcam), zona occludens-1 (Invitrogen),
collagen IV (Abcam), CD68 (Serotec), Insulin (Santa Cruz), and
caveolin-1 (Cav-1; Santa Cruz). Antibody binding was detected
by incubation with ﬂuorescein-, Alexa555-, Alexa488-, and
Alexa594-conjugated secondary antibodies. Finally, the nuclei
were stained with DAPI. Fluorescence was analyzed on a Leica
ﬂuorescence microscopy.11,21 We determined the number of
PECAM-1–positive, DAPI-stained cells per heart, pancreas,
kidney, adipose tissue, muscle, and liver by systematically
counting 6 to 10 microscopy ﬁelds on 10 sections per organ
analyzed (3 mice per genotype). For staining the tissue section
for Oil Red O, cryosections (5 lm) were ﬁxed in 10% formalin
for 30 minutes, and then washed in distilled water and stained
with 0.5% Oil Red O in isopropanol (Sigma Aldrich) for
30 minutes to identify neutral lipids, cholesterol, and fatty
acids (red color). Slides were then covered in aqueous mount
under a coverslip. Images from the stained slides of mice were
initially acquired using a 24-bit ﬁle format. ImageJ 1.37v
software (NIH) was used to convert bright-ﬁeld (24-bit)
images of Oil Red O staining to 8-bit images. Threshold values
were chosen that maximize selection of the Oil Red O–positive
tissue while minimizing background interference. Thus,
the total number of lipid drops from each image (percentage)
was quantiﬁed in the at least 20 random ﬁelds from each
samples.
RNA Extraction, Quantiﬁcation,
and RT-PCR Analysis
Total RNA was isolated from adult mouse organs with
TRIReagent (Molecular Research Center) and treated with
DNase, using the RNase-Free DNase Set (Fermentas), as
previously described.21 The GAPDH and b-actin housekeeping
genes were used as internal controls.21,22 All primer
sequences are given in Table 1. Results were analyzed with
use of Bio-Rad qPCR software, version 2.0. Primer sequences
are shown in Table 1.
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Biochemical Analyses on Blood
and Urine Samples
Blood samples and urine samples were collected and analyzed
as outlined on the Institute of Mouse Clinic (ICS) website
(http://www.ics-mci.fr/).
Contractility of Isolated Aortic Rings
Aortic segments dissected free of fat were mounted on a wire-
myograph (DMT) as previously described.23 Brieﬂy, wires were
inserted into the lumen of the arteries and ﬁxed to a force
transducer and a micrometer. Arteries were bathed in a
physiological salt solution (PSS) of the following composition (in
mmol/L): CaCl2 1.8, KCl 2.7, MgCl2 0.5, NaCl 136.9, NaHCO3
11.9, NaH2PO41.2, D-glucose 5.5, and HEPES 10. The pH of the
solution was 7.4. The isometric tension was recorded using a
force–displacement transducer so that isometric force mea-
surements could be performed (Biopac) and recorded using the
Acknowledge data acquisition and analysis software (Biopac).
The aortic rings were allowed to equilibrate for 30 minutes,
during which time the bathing PSS solution was replaced at
Table 1. Primers
Genes Forward Primer (5′?3′) Reverse Primer (5′?3′)
L2/L2 GACTGGACATCTAGTGGTAGTCAGG GGGTGTGAGGTGGGATTAAGTCAC
Tie-2 ATTCTCGTGGAACTGGATGG GGACAGGTAATGGTTGTCTGG
PPAR a ACGATGCTGTCCTCCTTGATG GTGTGATAAAGCCATTGCCGT
PPAR c CGAGAAGGAGAAGCTGTTGG GAAACTGGCACCCTTGAAAA
C/EBPa CAAGAACAGCAACGAGTACCG GTCACTGGTCAACTCCAGCAC
HIF 1a TACAAGGCAGCAGAAACCTAC TGTGCAATTGTGGCTACC
VEGF CTTCCTACAGCACAGCAGATGTGAA TGGTGACATGGTTAATCGGTCTTTC
Col 1a1 GCCAAGAAGACATCCCTGAAG TGTGGCAGATACAGATCAAGC
Col 1a2 CACCCCAGCGAAGAACTCATA GCCACCATTGATAGTCTCTCC
Col 3a1 TTTGTGCAAAGTGGAACCTG TGGACTGCTGTGCCAAAATA
LOX CCACAGCATGGACGAATTCA AGCTTGCTTTGTGGCCTTCA
meNOS TACGCACCCAGAGCTTTTCT GAACTGGAGGGGAGGAAGAC
Arg 1 CAGAAGAATGGAAGAGTCAG CAGATATGCAGGGAGTCACC
Arg 2 TGATTGGCAAAAGGCAGAGG CTAGGAGTAGGAAGGTGGTC
Gata 4 TCTCACTATGGGCACAGCAG GCGATGTCTGAGTGACAGGA
ANF CCTGTGTACAGTGCGGTGTC CCTGCTTCCTCAGTCTGCTC
a MHC GAGATTTCTCCAACCCAG TCTGACTTTCGGAGGTACT
b MHC CTACAGGCCTGGGCTTACCT TCTCCTTCTCAGACTTCCGC
FATP 1 GGCTCCTGGAGCAGGAACA ACGGAAGTCCCAGAAACCAA
FATP 4 GGCTTCCCTGGTGTACTATGGAT ACGATGTTTCCTGCTGAGTGGTA
Fabp 4 CAGAAGTGGGATGGAAAGTCG CGACTGACTATTGTAGTGTTTGA
IRS1 AGCCCAAAAGCCCAGGAGAATA TTCCGAGCCAGTCTCTTCTCTA
IR ATGAGGCCAACCTTCCTGGAA ACGGGACATTCTCCATGTCT
Flk-1 GATCACCATTCATCGCCTCT AAACATCTTCGCCACAGTCC
NCX-1 TGAGAGGGACCAAGATGATGAGGAA TGACCCAAGACAAGCAATTGAAGAA
Nephrin GACCGGGACACAAGAAGCTC GATGTCCCCTCAGCTCGAAG
NaPi II a AGACACAACAGAGGCTTC CACAAGGAGGATAAGACAAG
TGF b CTAATGGTGGACCGCAACAAC CGGTTCATGTCATGGATGGTG
b actin CATCTTGGCCTCACTGTCCA GGGCCGGACTCATCGTACT
GAPDH TGAGGCCGGTGCTGAGTATGTCG CCACAGTCTTCTGGGTGGCAGTG
Cav-1 CTCGAGATGTCTGGGGGCAAATACG GAATTCTATCTCTTTCTGCGTGCTG
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15 minutes intervals. Subsequently, 10 mN tension was
applied to each ring (representing the optimum stretch in this
preparation)23 and allowed to equilibrate for an additional
1 hour (with PSS solution replaced at 15 minutes intervals).
After equilibration, to test the contractile response of the tissue,
each ring was exposed to 125 mmol/L KCl. Cumulative
concentration–response curves were then obtained for the
responses to 0.01 to 10 lmol/L phenylephrine, 0.01 to
10 lmol/L acetylcholine (after preconstriction with phenyl-
ephrine to 50% of the maximum determined from the phenyl-
ephrine concentration–response curves).24
Insulin Stimulation of Akt Activity and
Nitric Oxide Synthetase Activity Detected
by Western Blot Assay
Animals were anesthetized with 1% pentobarbital, followed by
an intraperitoneal (i.p.) injection of insulin (150 mU/g,
Umaline Rapide). Ten minutes after injection, mice were
killed and tissues were harvested for protein extraction.
Tissue samples were homogenized in lysis buffer composed of
50 mmol/L Tris-HCl, pH 6.8, 1 mmol/L EDTA, pH 8.0, 1%
NP-40, 1 mmol/L NA3VO4, 0.1% SDS, 100 mmol/L NaCl, and
phosphatase and protease inhibitors. Homogenized samples
were incubated under agitation for 1 hour at 4°C, then
centrifuged at 13 000 rpm at 4°C to obtain protein extracts.
The protein concentration was measured by use of BCA assay
(Thermo Scientifc) as described in the manufacturer’s
instructions. Approximately 100 lg of protein for each
sample was separated by 12% SDS-PAGE, transferred to a
PVDF membrane, and incubated with anti–phospho-Akt
Ser473 (Cell Signaling; 1:1000 dilution), anti–phospho-Akt
Thr308 (Santa Cruz; 1:1000 dilution), or anti-Akt antibody
(Cell Signaling; 1:1000 dilution).
To investigate insulin-mediated NOS activity, ECs from
control and mutant mice were incubated with insulin
(10 nmol/L) for 5 minutes.25 Then, the lysed cell samples
were subjected to Western blot analysis using phospho–
endothelial nitric oxide synthesis (eNOS) (Ser1177) and eNOS
antibodies (Cell Signaling). Samples were treated with per-
oxidase-conjugated secondary antibody (Santa-Cruz; 1:5000
dilution), and immunoreactivity was detected by using the ECL
chemiluminescent detection kit according to the manufac-
turer’s speciﬁcations (Amersham Pharmacia). The intensity of
the resulting bands was quantiﬁed by use of ImageJ software.
Intraperitoneal Insulin Tolerance Test and
Intraperitoneal Glucose Tolerance Test
At 12, 24, and 36 weeks of age, the mice underwent an
intraperitoneal insulin tolerance test (ITT) after a 4-hour fast
or an intraperitoneal glucose tolerance test (GTT) without
fasting. insulin (Umuline Rapide [Lilly, France], 0.75 unit/kg
body weight), or glucose (1 mg/g body weight) in normal
saline (0.9% NaCl) was administered intraperitoneally. Blood
samples were taken from the tail vein at 0, 15, 30, 60, 90, and
120 minutes after loading, and plasma glucose levels were
measured using a Countour TS glucometer (Bayer). For
measurement of the plasma insulin levels, 4 hour after
fasting, 2 mg/g glucose was administered intraperitoneally.
Blood samples were taken at 0 and 15 minutes for measure-
ment of plasma glucose and insulin levels.26 Plasma glucose
levels were measured using the glucose oxidation method,
and insulin levels using an ELISA kit, as standardly performed
and outlined on the MCI website (http://www.ics-mci.fr/
test_glucose_tolerance.html).
Adenovirus Preparation and Injection
Adenovirus encoding PKR1 were generated as described
previusly.11 Brieﬂy 107 pfu/lL PKR1 or control adenovirus
(nonrecombinant) was injected 2 times at a 1-week interval via
the tail vein of control and mutant mice. All the experiments
were performed 2 to 3 weeks after the infections.
PKR1 and Cav-1 Knockdown
Knockdown of PKR111 and Cav-127 uing small interfering RNA
(siRNA) was performed on the ECs as described prreviously. The
oligonucleotide pairs of Cav-1 siRNA-1, siRNA-2, and siRNA-3
were used, and the sequences of the sense strands of Cav-1
siRNA-1, siRNA-2, and siRNA-3 are 5′-CCAUCAAUUUGGAGAC
UAUtt-3′, 5′-CCACUCAGCAACUGAAUGAtt-3′, and 5′-GUACCU
GAGUCUCCAGAAAtt-3′, respectively. To check for speciﬁcity,
negative control siRNAs was used: 5′-ACGACTAGCCTGAACTC
AA-3′. ECs were incubated in a 6-well tissue culture dishes
without antibiotics and 24 hours before transfection, resulting
in a 60% to 80% conﬂuency. Control siRNAs and speciﬁc Cav-1
siRNAs (100 nmol/L) were mixed with Lipofectamine TM2000
(Invitrogen) according to manufacturer’s recommendation and
added to the cells, respectively. After 6 hours at 37°C, the
medium was changed, and the cells were cultivated in DMSO
containing 10% FCS for 72 hours.
Statistical Analysis
Data are expressed as meanSEM. Statistical comparisons
for all experiments were performed using Mann–Whitney (for
2 groups) and Kruskal–Wallis (for >2 groups) tests. Excep-
tionally, statistical comparisons for Oil red O staining of
mouse tissues and CD68 staining of macrophages, PECAM-1
and a-SMA staining of vessels, TUNEL staining of mouse
tissues, and insulin staining of pancreas were performed using
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the unpaired Student’s t test and ANOVA. P<0.05 was
considered statistically signiﬁcant for all tests.
Results
Inactivation of the PKR1 Gene by tie2-cre–
Mediated Deletion Leads to PKR1 Loss in ECs
The genotype of each mouse was conﬁrmed with PCR on tail
biopsy samples (Figure 1A). Primer sequences are given in
Table 1. The ec-PKR1/ mice harbor the tie2-Cre transgene
and are homozygous for the PKR1 ﬂoxed allele (PKR1lox/lox).
Control mice are tie2-Cre negative and they are PKR1lox/+.
The endothelium-speciﬁc ablation of PKR1 were checked in
ec-PKR1 mice, by carrying out double ﬂuorescence staining
for the endothelial marker protein PECAM-1 (red) and PKR1
(green) in the aorta and primary aortic ECs. PKR1 protein
was detected in control (L2/L2+/+) mouse aorta (Figure 1B,
upper panel) and ECs (Figure 1B, lower panel) but not in
ec-PKR1/ mouse aorta and ECs. It has been argued that
the tie2-promoter might be also active in in bone marrow–
derived cells, monocytes, and neutrophils,28,29 but we ruled
out this possibility by showing normal PKR1 protein levels
(Figure 1C) as well as normal PKR1 transcript (Figure 1D,
right panel) in BM isolated from ec-PKR1/ mice and mRNA
expression in peripheral blood cells of ec-PKR1/ mice
(Figure 1D, left panel). PKR1 loss did not alter the expression
of PKR2 in the glomerular ECs (Figure 1E and 1F). Note that
PKR2 is not expressed in the aortic ECs. Taken together, we
conclude that ec-PKR1/ mice lack PKR1 speciﬁcally in
ECs.
EC-Speciﬁc PKR1 Ablation Triggers Defects
in Endothelial Relaxation, Proliferation,
and Capillary Formation
The ec-PKR1/ mouse aortas displayed abundant micro-
aneurysms and high levels of macrophage inﬁltration (Figure 2A).
Figure 1. Generation of endothelium-speciﬁc PKR1 loss in mice. A, Representative genotype analysis of ec-PKR1/ mice. Genomic DNA was
ampliﬁed with oligonucleotide primers detecting tie2-Cre and PKR1lox/lox alleles. The ec-PKR1/ mice harbor the tie2-Cre transgene and are
homozygous for the PKR1 ﬂoxed allele (PKR1lox/lox). Control mice are tie2-Cre negative and they are PKR1lox/+. B, Double staining for PKR1 and
PECAM-1 in the aorta and isolated aorta ECs (lower panel), showing the loss of PKR1 exclusively from ec-PKR1/ aortas and ECs. C, Immunostaining
analyses for PKR1 antibody revealed that PKR1 protein levels were not altered in bonemarrow (BM) derived from ec-PKR1/mice. Caveolin-1 levels
remained unaltered in ec-PKR1/ BM. D, Blood cells and BM derived from L2/L2 and ec-PKR1/ mice expressed the same level of PKR1
mRNA detected by RT-PCR (illustration) and quantitative PCR (qPCR) (histogram). E, PKR2 immunostaining of ECs, as well as F, RT-PCR
(illustration) and qPCR (histogram) analyses on RNA derived from ECs, revealed that the protein and transcript levels of PKR2 remained unaltered in
ECs of ec-PKR1/mice (P>0.05). DAPI indicates 4',6-diamidino-2-phenylindole, amarker of nucleus; EC, endothelial cell; ec-PKR1/, endothelium-
speciﬁc PKR1 knockout mice; L2/L2, PKR1+/+; PECAM-1, platelet–endothelial cell adhesion molecule 1; PKR, prokineticin receptor.
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Electron microscopy demonstrated the vacuolization of ECs
with macrophage attachments (Figure 2B). A tight junction
protein, zona occludens-1 immunostaining revealed a dis-
rupted endothelial organization in the mutant ECs (Figure 2C).
Endothelium-dependent (acetylcholine) relaxation differed
signiﬁcantly between control and mutant mice at the age of
24 weeks (Figure 2D). The eNOS, arginase-1, and arginase-2
deﬁciencies observed in mutant aorta may impair relaxation
(Figure 2E). PECAM-1 expression was similar in both groups of
mice. However, contraction in response to phenylephrine or a
calcium channel opener (U46619) and endothelium-indepen-
dent (sodium nitroprusside) relaxation in aortic rings were
similar in mutant and control mice (Figure 2F). The endothe-
lium-speciﬁc loss of PKR1 did not, therefore, alter aortic
vasomotor responses (Table 2), despite the progressive
impairment of endothelium-dependent relaxation.
Control primary ECs formed capillary-like structures in
response to prokineticin-2 on Matrigel, and these structures
connected to anastomozing networks within 16 hours of
culture (Figure 2G). In contrast, ec-PKR1/ ECs largely failed
to generate tubes, instead forming aggregates of cells. The
proliferation rate was increased by 8-fold in the ECs derived
from control mouse aorta, 4 days after treatment with
prokineticin-2 (10 nmol/L) and ﬁbroblast growth factor
(25 ng/mL). No visible prokineticin-2–mediated EC prolifera-
tion was detected in the absence of PKR1 in aortic ECs from
ec-PKR1/mice. The ﬁbroblast growth factor response also
differed considerably between mutant and wild-type cells
Figure 2. The loss of PKR1 in ECs affects endothelial function in vivo and in vitro. A, Histological analyses of aortas from control (L2/L2+/+) and ec-
PKR1/mice. Aortic rupture (arrow) was observed only in mutants (upper and lower panels). B, Electron microscopy showed defective endothelial
structures, vacuolar structures, and the attachment of macrophages (mc) to ECs of the ec-PKR1/ aortas at the age of 24 weeks. Smc, smooth
muscle cells; nc, nucleus. C, Impaired ZO-1 staining shows a junctinal defects in ECs. D, Impaired acetylcholine-induced relaxation in ec-PKR1/
aortas (n=6), as shown by comparison with L2/L2+/+ aortas (n=6). E, RT-qPCR analyses of RNA samples from L2/L2+/+ and ec-PKR1/ aortas,
showing a reduction of the expression of the NOS, arginase 1, arginase 2 genes, and an unaltered expression of PECAM-1 gene in ec-PKR1/
aortas (*P<0.001). F, Relaxation in response to endothelium-independent (sodium nitroprusside), or contraction in response to phenylephrine and
calcium channel opener (U46619), in aortic rings were similar in the 2 groups of mice, that is, in ec-PKR1/ aortas (n=6) compared with control
aortas (n=6). G, Representative in vitro assay of angiogenesis in response to prokineticin-2 (PK2) on Matrigel, with endothelial cells derived from
control (L2/L2+/+) and ec-PKR1/ hearts. H, Rate of proliferation of ECs derived from L2/L2+/+ or ec-PKR1/ hearts in response to FGF or
prokineticin-2, showing the impaired proliferation rate of mutant ECs (n=3, P>0.05); *(for FGF) indicate a signiﬁcant difference from control (blue)
(P<0.05) in ECs derived from aortas. I, Analysis of cell proliferation in response to PK-2 and FGF in primary glomerular ECs transfected with a control
siRNA (left panel) or a PKR1 siRNA (right panel) reveals a reduced proliferation rate of EC expressing low level of PKR1; *(for FGF) indicate a
signiﬁcant difference from control (blue) (P<0.05). RT-PCR analyses show that transfection of EC with siRNA for PKR1 reduces PKR1 levels in these
cells by 75%. Data are expressed as meanSEM (n=3). Arg indicates arginase; Cnt, control; EC, endothelial cell; ec-PKR1/, endothelium-speciﬁc
PKR1 knockout mice; FGF, ﬁbroblast growth factor; NOS, nitric oxide synthase; PECAM-1, platelet–endothelial cell adhesion molecule 1; PK-2,
prokineticin 2; PKR1, prokineticin receptor 1; siRNA, small-interfering RNA; SNT, sodium nitroprusside; ZO-1, zona occludens 1.
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(Figure 2H). The siRNA-mediated knockdown of PKR1 expres-
sion in primary glomerular ECs induced a defect in the
responses to prokineticin (10 nmol/L) (Figure 2I). The
defective angiogenesis resulting from the impairment of
mutant EC proliferation provided the ﬁrst clue to the
mechanisms potentially accounting for the phenotype of mice
lacking endothelial PKR1.
The EC-Speciﬁc Ablation of PKR1 Triggers Insulin
Resistance and Impaired Endothelial Insulin
Uptake
The ec-PKR1/ mice had symptoms of polyphagia, polydip-
sia, and polyuria at the age of 24 weeks, despite having a
similar body weight to wild-type mice (Figure 3A). Moreover,
ec-PKR1/ mice had high levels of urinary glucose excretion
(Figure 3B, left panel) and high basal serum insulin concen-
trations (0 minutes) (Figure 3B, right panel). Control mice
displayed a signiﬁcant increase in serum insulin concentration
20 minutes after glucose injection, whereas no such increase
was observed in mutant mice (Figure 3B, right panel),
indicating an impairment of glucose-induced insulin secretion
in the mutant mice. GTTs revealed a delayed response to
hyperglycemia, with signiﬁcant increases in blood glucose
concentrations observed at 30, 90, and 120 minutes in ec-
PKR1/ mice at the age of 24 weeks (Figure 3C, upper
panel). These mutant mice also had higher glucose levels in
the ITT (Figure 3C, lower panel). These changes in GTT and ITT
were not signiﬁcant in younger mutant mice (12 weeks old).
Thus, ec-PKR1/ mice were signiﬁcantly less sensitive to
insulin than control mice, as shown by their higher glucose
concentrations in the GTT and ITT and their prediabetic state
at the ages of 24 and 36 weeks. Our mice model exhibit
hyperinsulinemia and postprandial hyperglycemia as charac-
teristics of type 2 diabetes.
We then investigated insulin delivery to ECs, a rate-limiting
step in the peripheral action of insulin potentially contributing to
insulin resistance.30,31 FITC-insulin immunoreactivity (detected
with an antibody against FITC) was observed in the ECs and
innermost layer of the blood vessel wall in control cardiac, renal,
and adipose tissues 10 minutes after its administration. No
ﬂuorescence of vessel ECs was detected after non–FICT-insulin
injection. However, FICT-insulin uptake in the ECs of themutant
adipose tissue, heart, and kidney was severely affected (Figure
3D and 3E). Thus, the transcapillary transport of insulin was
defective in the mutant endothelial wall.
We then investigated the role of PKR1 in insulin uptake in
isolated ECs. Isolated ECs from the cardiac, glomerular, and
adipose tissues of control mice took up FITC-insulin within
30 minutes (Figure 3F, left panel and histogram). However,
very little insulin was taken up by ECs derived from the
mutant cardiac, glomerular, and adipose tissues (Figure 3F,
right panel and histogram). We then investigated the effect of
PKR1 overexpression in cultured glomerular endothelial cells
(glomEC-PKR1) on FITC-insulin uptake. We conﬁrmed that
total PKR1 expression (endogenous+infected with adenovirus
carrying PKR1 cDNA) was signiﬁcantly higher (50%5%
higher) in the transfected cells than in the control cells. The
glomEC-PKR1 cells took up 2.50.18 times more FITC-insulin
than control cells infected with adenovirus-control (glomEC),
over a 30-minute period (Figure 3G). We investigated the role
of PKR1 in insulin uptake further, by treating these cells with
prokineticin-2. This treatment (10 nmol/L prokineticin-2)
induced the uptake of twice as much FITC-insulin, in a time-
dependent manner, in glomEC-PKR1 cells as in glomECs
(Figure 3H) (*P<0.05 for each), highlighting the role of PKR1
as a positive regulator of insulin uptake.
Next, we investigated whether insulin signaling is altered in
mutant ECs. We also found an impaired insulin-mediated NOS
activation in all mutant ECs (Figure 4A and histograms). The
eNOS protein levels in all mutant ECs were also lower,
consistent with reduced NOS transcriptional levels (Figure 2E).
Cav-1 plays an important role in angiogenesis,32 insulin
uptake,27 and G protein–coupled receptor trafﬁcking.33 We
therefore investigated the levels of this compound in control
ECs, ECs overexpressing PKR1, and ECs lacking PKR1. Cal-1
levels were closely correlated with PKR1 expression levels
(Figure 4B and histogram). Thus, ec-PKR1 mutant mice had
low concentrations of Cav-1 in their aortas (Figure 4B, right
panel). Cal-1 knockdown by siRNA for Cav-1 in ECs
diminished insulin uptake in ECs overexpressing PKR1,
indicating that Cav-1 acts as an intermediary between PKR1
and insulin trafﬁcking (Figure 4C).
EC-Speciﬁc Ablation of PKR1 Induces
Lipodystrophy
We investigated the pathological consequences of impaired
EC proliferation and insulin uptake in the tissues to which
insulin is targeted. The ec-PKR1/ mice had a lower white
abdominal fat mass (1.2810.19 g) than control mice
(1.930.19 g, n=6, P<0.05) at the age of 36 weeks. This is
consistent with the slightly lower body weights of mutant
mice (35.51.06 g) than of control mice (37.61.39 g) at
the age of 36 weeks. The ec-PKR1/ mice mouse adipo-
cytes were heterogeneous in size and were interspersed with
very pronounced “streaks” (Figure 5A) composed of CD68-
positive macrophages (Figure 5B). Electron microscopy
showed the diameter of the mutant vessels to be highly
variable in ec-PKR1/ adipocytes, which also had small
numbers of mitochondria (Figure 5C). GTT revealed a delayed
response to hyperglycemia, with signiﬁcant increases in blood
glucose concentrations observed at 15, 30, and 60 minutes
in ec-PKR1/ mice at the ages of 36 weeks (Figure 5D, left
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panel). These mutant mice also had higher glucose levels in
the ITT (Figure 5D, right panel). Mutant mice displayed
signiﬁcantly lower levels of capillary formation than control
mice, as shown by PECAM-1 staining at the age of 36 weeks
(Figure 5E). Indeed, hypoxia-inducible factor 1a (HIF1a)
transcription were 80%5.2% higher in ec-PKR1/ adipo-
cytes than in control adipocytes, whereas the expression of
proangiogenic genes, such as that encoding vascular endo-
thelial growth factor (VEGF), was unaffected (Figure 5F). The
ec-PKR1/ mice displayed higher levels of ﬁbrillar collagen
deposition in adipose tissue (Figure 5G), partly due to higher
levels of expression of HIF1aregulated ﬁbrotic genes, such
Figure 3. The loss of PKR1 leads to insulin resistance and impaired insulin uptake. A, Metabolic cage analyses revealed that ec-PKR1/ mice
had greater intakes of food (g/24 h) and water (mL/24 h) and a greater urine volume (mL/24 h) than control (L2/L2+/+) mice at the age of
24 weeks. The data shown are meansSEM (n=6 for all groups, *P<0.05). Body weight (g) was similar in all groups. B, Urinary glucose
concentration was higher in the mutant mice. Serum insulin concentration was higher in the mutant mice (n=6 for all the groups, *P<0.05).
Glucose-induced insulin release was signiﬁcant in control mice (†P<0.05) but impaired in mutant mice, 20 minutes after glucose injection. C, GTT
and ITT analyses show impaired glucose clearance and insulin tolerance in the ec-PKR1/ mice at the age of 24 weeks (n=6 for each group,
*P<0.05). D, Representative illustration of insulin uptake in the blood vessels of the adipose tissue, kidney and heart, 10 minutes after FITC-insulin
intravenous injection into L2/L2+/+ and ec-PKR1/ mice. E, The histogram shows that FITC insulin uptake was signiﬁcantly lower in ec-PKR1/
blood vessels than in control blood vessels (n=4, *P<0.05). F, Representative illustration of insulin uptake by ECs derived from the heart (card-EC),
glomerulus (glom-EC), and adipocytes (adip-EC) of mutant and control animals, 30 minutes after insulin-FITC loading. No insulin uptake was
observed in mutant ECs (histogram, n=3, *P<0.05). Scale bar=30 lm. G, The infection of glomerular ECs with an adenovirus carrying PKR1 cDNA
(Adv-PKR1) increased insulin uptake within 30 minutes, as shown by comparison with Adv-control–infected glomerular ECs. Scale bar=10 lm. H,
Prokineticin-2 (PK-2) promoted higher levels of insulin uptake in Adv-PKR1–infected cells than Adv-control–infected cells, indicating an essential
role for PKR1 in insulin uptake (n=5 for all groups, *P<0.05). Adip indicates adipose; Card, cardiac; EC, endothelial cell; ec-PKR1/, endothelium-
speciﬁc PKR1 knockout mice; glom, glomeruli; AGTT, glucose tolerance test; ITT, insulin tolerance test; FITC, ﬂuorescein isothiocyanate.
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as those encoding lysyl oxidase (LOX) and collagens 1a1, 1a2,
and 3a (Figure 5F). TUNEL assays showed apoptosis levels to
be higher in mutant than in control adipose tissue (Figure 5H
and histogram). The lower levels of free fatty acid (FFA)
transporters FATP-1, FATP-4, and FABP in mutant adipocytes
(Figure 5I) are associated with the higher serum FFA
concentrations in mutant than in control mice (L2/L2+/+)
(Figure 5I, middle). Consistent with the observed lipodystro-
phy, circulating leptin concentrations were also found to be
50% lower in ec-PKR1/ mice than in control (L2/L2) mice
(Figure 5I, right). Levels of mRNA encoding insulin receptor
substrate-1 and insulin receptor were also lower in mutant
adipoytes than in control cells, by a factor of 1.50.1. Mutant
adipocytes were resistant to the action of insulin, as shown by
the signiﬁcantly lower levels of threonine and serine phosphor-
ylation of Akt following insulin stimulation (Figure 5J). Thus,
ec-PKR1/ mice display lipodystrophy accompanied by
peripheral insulin resistance.
EC-Speciﬁc Ablation of PKR1 Triggers Heart
Defects
We next investigated how the cardiovascular system was
affected by investigating heart structure and function in
ec-PKR1/ mice at the ages of 12 and 24 weeks. Posterior
wall thickness was thinner in of ec-PKR1/ mice
(0.840.02 mm) than in control mice (0.750.03 mm) at
the age of 12 weeks (n=8, P>0.05). Despite an increase in
left ventricular end-systolic diameter, no detectable changes
in the heart functions were found in the ec-PKR1/ mice at
this age (Table 2). Histological analysis of the hearts of
24-week-old mice revealed the reduced the ventricular wall in
Figure 4. Impaired eNOS activity and caveolin-1 levels in mutant endothelial cells. A, eNOS was phosphorylated at serine 1177, 5 minutes after
insulin (10 nmol/L) treatment of cardiac endothelial cells (cEC), glomerular EC (glom ECs) and adipocyte tissue ECs (adip ECs) from control mice.
In contrast, insulin was not able to induce phosphorylation of eNOS in any of the mutant ECs. Note that total eNOS level were reduced in mutant
cECs, glom ECs and adip ECs by 607%, 558%, and 405%, respectively (n=3, *P<0.05). B, Representative illustration of calveolin-1 levels. The
histogram shows the regulation of calveolin-1 levels by the PKR1 expression level in ECs (blue), ECs overexpressing PKR1 (black) and PKR1-
mutant ECs (red) (†*P<0.05). RT-PCR analyses showed that mutant aortas contained less caveolin-1 than control aortas (n=4, *P<0.05).
C, Calveolin-1 siRNA reduced caveolin-1 expression by 75% in ECs within 72 hours. Caveolin-1 knockdown by siRNA (Cav-1-EC) in Adv-PKR1–
expressing cells had a lower prokineticin-2–mediated insulin uptake within 15 minutes, compared with ECs expressing a nonspeciﬁc siRNA
(NC-EC) (*P<0.05). Adv-PKR1 indicates adenovirus carrying prokineticin receptor 1; ec-PKR1/, endothelium-speciﬁc PKR1 knockout mice;
eNOS, endothelial nitric oxide synthase; siRNA, small-interfering RNA.
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Figure 5. Impaired structures, capillary formation, and insulin signaling in ec-PKR1 adipocytes. A, Semi-thin sections of adipose tissue showing
the heterogeneity of mutant adipocyte size. The arrow shows streaks in the mutant adipocytes. B, CD68 staining on cryosectioned adipose tissue
revealed a high level of macrophage inﬁltration in the interstitial area of adipose tissue in ec-PKR1/ mice (illustration and histogram, n=3,
*P<0.01). C, Electron microscopy analyses revealed a loss of mitochondria (mtc) and small blood vessel (bv) structures in mutant adipocytes.
D, GTT and ITT analyses show impaired glucose clearance and insulin tolerance in the ec-PKR1/ mice at the age of 36 weeks (n=6 for each
group, *P<0.05). E, PECAM-1 immunostaining on cryosectioned adipocytes, showing capillary regression in mutant adipocytes. Scale bar=10 lm.
F, RT-PCR analyses demonstrated an increase in the expression of HIF1a but not of VEGF in mutant adipocytes (n=3, *P<0.05). RT-qPCR showed
the higher levels of ﬁbrotic gene expression in ec-PKR1/ adipocytes than in control L2/L2+/+adipocytes (n=3, *P<0.05; scale bar=20 lm).
G, Double-staining of collagen VI and a-SMA on cryosectioned adipocytes, showing higher levels of collagen deposition in the mutant adipocytes
(illustration and histogram, *P<0.01). H, TUNEL staining of an adipocyte section showing a greater abundance of apoptotic cells in mutant
adipocytes than in control adipocytes (*P<0.01). Scale bar=10 lm. I, qPCR analysis showed lower levels of expression of the insulin receptor (IR),
insulin receptor substrate (IRS) and free fatty acid (FFA) transporter (FABP, FATP1 and 4) genes (n=3, *P<0.05). Serum FFA concentrations were
higher, but leptin concentrations were lower in ec-PKR1/ than in L2/L2+/+ mice (n=6 for all groups, *P<0.05). J, Western blot analyses showed
an impairment of Akt phosphorylation (Ser473 and Thr308) 10 minutes after insulin administration (i.p.) in ec-PKR1/ adipocytes (n=3,
†*P<0.05). ec-PKR1/ indicates endothelium-speciﬁc PKR1 knockout mice; GTT, glucose tolerance test; HIF1a, hypoxia-inducible factor 1; ITT,
insulin tolerance test; PECAM-1, platelet–endothelial cell adhesion molecule 1; PKR1, prokineticin receptor 1; TUNEL, terminal deoxynucleotidyl
transferase dUTP nick end labeling; SMA, smooth muscle actin; VEGF, vascular endothelial growth factor.
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ec-PKR1/ mice (Figure 6A). Semi-thin sections showed
cellular disorganization and disruption in the mutant hearts
(Figure 6B). Electron microscopy showed undulating ECs,
myoﬁbril disorganization, short sarcomeres, and swollen
mitochondria. Echocardiography showed the left ventricular
end-systolic and end-systolic diameters are signiﬁcantly
higher in 24-week-old mutants than in controls (Figure 6C).
Consistent with this ﬁnding, left ventricular volume was
signiﬁcantly greater during diastole and systole (Figure 6C
and Table 2). Shortening fractions (indicators of left ventric-
ular contractility) differed signiﬁcantly between mutant and
control mice at 24 weeks (Table 2). RT-qPCR analysis showed
expression levels of the col1a1, col1a2, and col3A genes to
be higher in mutant mice than in controls, consistent with the
development of severe cardiac ﬁbrosis in the mutant mice
(Figure 6D). Levels of expression of hypertrophic genes, such
as those encoding atrial natriuretic factor and the b/a–
myosin heavy chain, were higher in mutant than in control
hearts (Figure 6D). The level of capillary formation in hearts
was signiﬁcantly lower in mutant mice than in control mice
(Figure 6E). TUNEL-positive myocardial cells (green) were
abundant in mutant hearts (Figure 6F), and inﬁltrating CD68-
positive macrophages (red) were twice as frequent in mutant
as in control hearts (Figure 6G, lower panel and histogram).
Insulin-mediated Akt phosphorylation levels were lower in
mutant hearts than in control hearts (Figure 6H). The ec-
PKR1/ mice had signiﬁcantly higher levels of myocardial
lipid accumulation than control mice, as shown by Oil Red O
staining (Figure 6I). The mutants displayed an evident loss of
capillaries from the skeletal muscle (Figure 6J). Lower levels
of insulin signaling and lipid accumulation in the skeletal
muscle of ec-PKR1/ mice were shown in Figure 6J and 6K.
The lipid accumulation (Figure 7A) and capillary levels (Figure
7B) in the liver of ec-PKR1/ mice were unaffected by the
loss of endothelial-PKR1, because hepatic sinusoidal ECs
express only PKR2 receptors.15 In contrast, transcript levels
for FFA transporters and insulin receptor were similar in the
liver (Figure 7C), heart, and skeletal muscles (Figure 7D) of
mutant and control mice. Note that transcript levels of
uncoupling proteins UCP2 and UCP3 (as mediators of
thermogenesis and energy balance in skeletal muscle) were
similar in ec-PKR1 and control heart and skeletal muscles
(Figure 7D).
EC-Speciﬁc Ablation of PKR1 Triggers Renal
Defects
We extended these cellular studies to an in vivo system, by
investigating kidney structure and function in ec-PKR1/
mice at the age of 12 and 24 weeks. Clear dilatation of the
Bowman’s spaces was observed in most of the mutant
glomeruli, with a compact glomerulus, glomerular ﬁbrosis, and
enlarged tubular structures in 12-week-old mice (Figure 8A
and 8B). Electron microscopy of the mutant kidneys showed
dilated tubules, with a swollen necrotic nucleus, abnormal
mitochondria, and incorrect organization of podocytes
within the glomerular structures (Figure 8C). At 12 weeks,
ec-PKR1/ mice had higher levels of absolute renal phos-
phate (Pi) excretion than control mice (Figure 8D), indicating
abnormal tubular function. PECAM staining revealed that the
level of capillary formation in the kidneys was signiﬁcantly
lower in mutant mice than in control mice (Figure 8E and
histogram). Tubular defects were evident, with lower levels of
transcripts for sodium-calcium (NCX-1) and sodium phosphate
(NaPi-IIa) exchangers than in control mice. Low levels of the
glomerular slit diaphragm protein nephrin may have resulted
Table 2. Ecocardiographic Analyses of 12- and 24-Week-Old
Male Mice
L2/L2+/+ ec-PKR1/
Echocardiographic analyses (12-week-old mice, n=8 for each group)
Heart rate, bpm 549.087.73 531.9115.754
LVEDD, mm 3.850.08 4.390.120*
LVESD, mm 2.110.07 2.370.109
Septal wall thickness, mm 0.930.05 0.850.032
Fractional shortening, % 45.131.21 46.051.945
Ejection fraction, % 0.8340.01 0.830.017
Echocardiographic analyses (24-week-old mice, n=6 for each group)
Heart rate 44037.9 46132.48
MAP, mm Hg 10215 11510
Diastolic parameters
LVEDD, mm 3.910.159 4.460.218*
LVPW, mm 1.0090.035 0.8780.068*
LV vol, lL 67.227.137 92.05510.626*
Systolic parameters
LVESD, mm 2.7260.201 3.2720.291*
LVPW, mm 1.390.086 1.2250.142
LV vol, lL 29.173.47 45.945.54*
Ejection fraction, % 58.104.51 52.495.35
Fractional shortening, % 36.673.26 27.283.39*
E wave, mm/s 83556.5 78430.18
A wave, mm/s 49869 43539
E/A ratio 1.7360.18 1.9860.23
IVRT, ms 23.212.62 212.12
IVCT, ms 18.933.05 16.661.53
ec-PKR1/ indicates endothelium-speciﬁc PKR1 knockout mice; E/A ratio, early (E) to
late (A) ventricular ﬁlling velocities; IVCT, isovolumetric contraction time; IVRT,
isovolumetric relaxation time; LV vol, left ventricular volume; LVEDD, left ventricular end-
diastolic diameter; LVESD, left ventricular end-systolic diameter; LVPW, left ventricular
posterior wall; MAP, mean arterial pressure.
*P<0.05.
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Figure 6. Impaired heart structure and function in mutant mice. A, Histological analysis, with Mallory tetrachrome staining, of L2/L2+/+ and
ec-PKR1/ heart sections, showing a thinner ventricular wall in ec-PKR1/ hearts (n=5). B, Semi-thin sections of hearts, demonstrating higher
levels of cellular disarray in the subepicardium and myocardium of ec-PKR1/ mice. Electron microscopy revealed undulating ECs, shortened
sarcomeres (z bands) and swollen mitochondria (mtc). C, Echocardiographic analyses showed left ventricular internal diameters and volume in
diastole to be greater in ec-PKR1/ hearts (n=6, *P<0.05). D, RT-qPCR showed higher levels of hypertrophic (Gata 4, a- and b-myosin heavy
chain) and ﬁbrotic (collagens 1a, 2, and 3a) gene expression in ec-PKR1/ hearts (*P<0.05, n=3). E, Capillary regression in mutant hearts,
detected by PECAM-1 staining (*P<0.05; scale bar=20 lm). F, Illustrations and the histogram show larger numbers of TUNEL-stained apoptotic
nuclei in ec-PKR1/ heart sections (*P<0.05, n=4). Scale bar=20 lm. G, Illustrations and the histogram show higher levels of CD68-positive
macrophage inﬁltration around the blood vessels of the ec-PKR1/ hearts (*P<0.05). Scale bar=10 lm. H, Western-blot analyses
demonstrating an impairment of Akt phosphorylation (Ser473) 10 minutes after insulin administration (i.p.) in mutant hearts, with respect to
control hearts (n=3, †*P<0.05). I, Oil Red O staining showing lipid accumulation in the ec-PKR1/ hearts (*P<0.05). Scale bar=20 lm. J, Lower
levels of capillary formation, as shown by PECAM-1 staining, and higher levels of lipid accumulation, as shown by Oil Red O staining, were
detected in the ec-PKR1/ skeletal muscles (*P<0.05). Scale bar=10 lm. K, Western-blot analyses demonstrating an impairment of Akt
phosphorylation (Ser473) 10 minutes after insulin administration (i.p.) in mutant hearts with respect to control hearts (n=3, †*P<0.05). ANF
indicates atrial natriuretic factor; EC, endothelial cell; ec-PKR1/, endothelium-speciﬁc PKR1 knockout mice; MHC, myosin heavy chain;
PECAM-1, platelet–endothelial cell adhesion molecule 1; PKR1, prokineticin receptor 1; TUNEL, terminal deoxynucleotidyl transferase dUTP nick
end labeling.
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in abnormal podocyte architectures in mutants (Figure 8F).
The morphological changes were associated with higher levels
of the inﬂammatory cytokine transforming growth factor-b in
mutant kidneys at the age of 24 weeks. The glomeruli of
mutant kidneys contained signiﬁcantly larger numbers of
TUNEL-positive cells (green) than those of control kidneys
(Figure 8G and histogram). Insulin-mediated Akt phosphory-
lation (serine 473) was signiﬁcantly impaired in mutant
kidneys at the age of 24 weeks (Figure 8H). Lipids accumu-
lated ectopically in the kidneys of ec-PKR1/ mice, as shown
by Oil Red O staining (Figure 8I). All urinary ion levels (mmol/L)
were lower in ec-PKR1/ mice than in controls, because of
high rates of urine ﬂow over a period of 24 hour at the age of
24 weeks (Table 3). Thus, endothelial-PKR1 regulates glomer-
ular and tubular capillary formation and renal metabolism and
functions.
EC-Speciﬁc Ablation of PKR1 Triggers
Hypertrophy of Pancreas b Cells
We investigated whether insulin resistance induced a com-
pensatory expansion of b-cell mass leading to hyperinsulin-
emia in mutants, by determining the number of pancreatic b
cells and insulin levels in ec-PKR1/ and L2/L2+/+ mice.
The number of insulin-positive beta cells did not differ
signiﬁcantly between these 2 groups of mice (Figure 9A and
9B, left panel, *P<0.05). In contrast, insulin-positive cells
were larger in the mutant pancreas, as demonstrated by
Figure 7. No pathological alteration in the mutant livers. A, Illustration of Oil Red O staining of liver from control and mutant mice,
demonstrating no difference in lipid accumulation in liver cells (histogram, P>0.05). B, Illustration of PECAM-1 staining of liver of control and
mutant mice, demonstrating no difference in capillary formation in the liver of both genotypes (histogram, P>0.05). C, Expression of FFA
transporters and insulin receptor detected by qPCR was not altered in mutant liver (n=3, P>0.05). D, qPCR analyses revealed that expression of
FFA transporters (FATP1, FATP4, and FABP), insulin receptor (IR), uncoupling proteins (UCP2 and UCP3) was not altered in mutant skeletal muscle
and heart (n=3, P>0.05). ec-PKR1/ indicates endothelium-speciﬁc PKR1 knockout mice; FFA, free fatty acid; PECAM-1, platelet–endothelial cell
adhesion molecule 1; qPCR, quantitative PCR.
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b-catenin staining (Figure 9A, lower panel, and 9B, right
panel, *P<0.05). Thus, insulin resistance in ec-PKR1/
induced a compensatory hypertrophy of b cells, leading to
hyperinsulinemia.
Reversal of the Disorders in ecPKR1/ Mice by
the Forced Expression of PKR1
We investigated whether it was possible to rescue this
phenotype by forced PKR1 expression in ec-PKR1/ mice. It
has been shown that, when delivered intravenously directly
into the bloodstream, adenoviruses ﬁrst encounter the heart
and lungs and then travel to the periphery via the aorta and
arteries before being distributed to the liver, spleen, and
kidneys.34 A recombinant adenovirus carrying PKR1 cDNA
(Adv-PKR1) was delivered intravenusly to ec-PKR1/ and
control mice. This intravenous injection of Adv-PKR1 led to a
tripling of PKR1 levels in the adipocytes of control mice
2 weeks after infection. The aortic ECs clearly expressed
PKR1 after the infection of ec-PKR1/ mice with Adv-PKR1
Figure 8. Impaired kidney structure and function in mutant mice. A, Semi-thin sections of kidneys showing a compact glomerulus (glm) and
larger than control Bowman’s capsules in mutant kidneys (n=5). B, Mallory tetrachrome staining of kidney sections showing hemorrhage (red) and
glomerular ﬁbrosis (blue) in the glomerula of ec-PKR1/ kidneys (upper panel). Large loss of tubular cells from mutant tubules. C, Electron
microscopy analyses on kidney samples revealed a lower cellular content of tubules (tbl) and abnormal podocyte (pod) structures and necrotic
nuclei (nc) in ec-PKR1/ kidneys (lower image). D, The histogram shows that levels of phosphate excretion in the urine of L2/L2+/+ mice were
higher than those of L2/L2+/+mice. The data shown are meansSEM, n=6 for each group, at the age of 24 weeks (*P<0.05). E, PECAM-1
analyses on cryosectioned kidneys revealed capillary regression in both the glomerular and interstitial areas (n=3, *P<0.05). Scale bar=10 lm. F,
qPCR analyses on the kidney samples revealed that ec-PKR1/ kidneys had higher levels of TGF-b and lower levels of nephrin, NaPi, and NCX
mRNA. (n=3, *P<0.05). G, Representative illustration of TUNEL analyses on kidneys. The histogram and images show larger numbers of TUNEL-
positive apoptotic cells (green) in ec-PKR1/ glomeruli (*P<0.05). Scale bar=10 lm. H, Western-blot analyses demonstrating an impairment of
Akt phosphorylation (Ser473), 10 minutes after insulin administration (i.p.), in ec-PKR1/ kidneys (n=3, †*P<0.05). I, Oil Red O staining showing
lipid accumulation in the ec-PKR1/ kidneys (*P<0.05). Scale bar=20 lm. ec-PKR1/ indicates endothelium-speciﬁc PKR1 knockout mice;
NaPi, transcripts for sodium phosphate; NCX-1, transcripts for sodium-calcium; PECAM-1, platelet–endothelial cell adhesion molecule 1; qPCR,
quantitative polymerase chain reaction; TGF, transforming growth factor; TUNEL, Terminal deoxynucleotidyl transferase dUTP nick end labeling.
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(Figure 10A). In each case, L2/L2 mice infected with the Adv-
control were identical to untreated mice. The difference in
capillary formation in the adipose tissues control and mutant
mice was abolished by Adv-PKR1 treatment (Figure 10B and
histogram). Endothelial insulin uptake in mutant mice was
restored by Adv-PKR1 infection (Figure 10C). The rescue of
PKR1 expression by the injection of an adenovirus into ec-
PKR1/ mice resulted in lower levels of food and water
intake and urine volume than in ec-PKR1/ mice treated
with Adv-control (Figure 10D). Similarly, glucose intolerance
and insulin resistance in ec-PKR1/ mice were clearly
attenuated by PKR1 replacement (Figure 10E). Consistent
with this ﬁnding, the serum insulin and creatine phosphoki-
nase concentrations of mutant mice after PKR1 gene
replacement were similar to those of control mice treated
with Adv-PKR1 or Adv-control (Figure 10F). The genes involved
in FFA (FABP, FATP1, and FATP4) uptake and insulin signaling
(insulin receptor and insulin receptor substrate-1), were
signiﬁcantly more strongly expressed in the adipocytes of
ec-PKR1/ mice treated with Adv-PKR1 than in those
treated with Adv-control (Figure 10G). The strong expression
of hypertrophic markers in mutant hearts was signiﬁcantly
decreased by the Adv-PKR1 treatment of mutant mice (Figure
10H). Similarly, the differences in expression of the NaPi,
NCX, TGF-b, nephrin, and FLK1 genes in between mutant and
control kidneys were abolished by the treatment of mutant
mice with AdV-PKR1 (Figure 10I). Thus, forced PKR1 expres-
sion in the ec-PKR1/ mice rescued the observed pheno-
type.
Discussion
Our results highlight a novel role for endothelial-PKR1
signaling in cardiac, renal, and metabolic functions by
orchestrating the survival, proliferation, and insulin uptake
of the ECs. Moreover, PKR1 loss in the endothelium results in
capillary refraction, the impairment of endothelium-dependent
relaxation, apoptosis, ﬁbrosis, and changes in insulin signal-
ing, leading to lypodystrophy, insulin resistance, and heart and
kidney defects (Figure 11).
The defective tube formation by ECs derived from ec-
PKR1/ mice results from impaired EC proliferation—an
important step in angiogenesis.35 The impaired capillary
formation observed in the ec-PKR1/ heart, kidney, and
adipose tissue identiﬁes PKR1 as a regulator of angiogenic
programs in adult tissues. These ﬁndings are supported by in
Table 3. Urine Analyses of 12- and 24-Week-Old Mice
Urine Analysis
12 Weeks 24 Weeks
Control (L2/L2) Mutant (ecPKR1/) Control (L2/L2) Mutant (ecPKR1/)
Urea, mmol/L 121786 131665 1532.0276.68 801.0137.96
Urea, lmol/24 h per g 71.665 62.506 50.9813.00 95.463.66*
Creatinine, lmol/L 485726 594721 4760.001108 2345.00412.56
Creatinine, nmol/24 h per g 291.1220 276.7122 136.13520 278.07211*
Urea/creatinine, mol/mol 247.37 220.36 352.95153 343.5375.70
Phosphate, mmol/L 23.902.5 55.464.0* 69.76215 35.5605.60
Phosphate/creatinine, mol/mol 5.0030.51 9.5020.69* 14.5701.2 14.5481.77
Ca, mmol/L 1.7740.22 1.4810.09 2.9780.87 2.8400.64
Ca/creatinine, mol/mol 0.3640.04 0.2510.01 0.6290.07 1.2430.21
Na, mmol/L 16111 17010 127.20025 71.0016.42
Na/creatinine, mol/mol 33.191.22 28.611.28 28.9744.6 29.4191.89
K, mmol/L 27818 29613 268.64036.5 165.40027.36
K/creatinine, mol/mol 56.881.31 49.791.19 64.05410.1 71.4531.94
Cl, mmol/L 18812.34 19812.03 147.40034.3 71.75013.01
Cl/creatinine, mol/mol 38.581.29 33.211.47 32.5785.12 30.8771.25
Glucose, mmol/L 1.8130.12 2.2380.12 2.3600.35 2.0000.38
Glucose, lmol/24 h 1.1610.15 1.9520.28* 2.9151.23 7.5180.59*
Glucose/creatinine, mol/mol 0.3930.03 0.3760.01 0.6130.20 0.8450.03
Glucose balance, lmol/g 0.1170.01 0.1060.01 0.0950.04 0.2360.02*
ec-PKR1/ indicates endothelium-speciﬁc PKR1 knockout mice.
*P<0.05.
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vitro studies showing that PKR1 signaling regulates the
survival, proliferation, and migration of ECs.15,36 Prokineticin-
2 can also induce proliferation, migration, and angiogenesis in
isolated cardiac ECs, by activating Ga11/MAPK and Akt
kinases. We show here that PKR1 in ECs is involved in
regulating endothelium-derived relaxation, capillary formation,
and insulin uptake. Mice lacking the eNOS gene develop
modest hypertension while still young. However, blood
pressure in male NOS/ mice decreases at older ages,
due to cardiac dysfunction.37 Blood pressure changes despite
the presence of low levels of NOS in the endothelium are
probably masked by the cardiac dysfunction in ec-PKR1/
mice. Similarly, altered eNOS activation and weak insulin
action have recently been demonstrated in the endothelium of
patients with diabetes mellitus.38 A nitric oxide deﬁciency of
endothelial origin is thought to be the primary defect linking
insulin resistance and endothelial dysfunction.39 Concomi-
tantly, we found an impaired insulin uptake and insulin-
mediated eNOS activation in all mutant ECs. Thus, impaired
insulin delivery in ECs may lead to defective NOS and eNOS
activation in the ec-PKR1/ aorta, consequently impairing
endothelium-dependent relaxation.
PKR1 loss is accompanied by impaired proliferation,
capillary formation, and insulin uptake. Conversely, PKR1
overexpression promotes insulin uptake in ECs and angio-
genesis.15 Transcapillary insulin transport is the rate-limiting
step in the peripheral action of insulin, and the impairment of
these processes contributes to insulin resistance.30,31
Accordingly, impaired insulin delivery and signaling in ECs
have been shown to cause insulin resistance in skeletal
muscle.2 Impaired endothelial insulin transport has been
observed in cases of insulin resistance with type 2 diabetes
and obesity. Our in vivo and in vitro data clearly show that
PKR1 controls endothelial insulin uptake, via Cav-1 signaling.
Cav-1 is required for insulin uptake by ECs27 and plays an
important role in the process of angiogenesis.32 Cal-1–null
mutant mice also have vascular abnormalities, due to aberrant
endothelial function,40 lipodystrophy-dependent insulin resis-
tance, and heart and kidney defects,41–43 resulting in a
phenotype similar to that of ec-PKR1/ mice. Gaq–Cav-1
interactions promote the internalization of receptors, includ-
ing G protein–coupled receptors and insulin receptors.33 We
found that protein and mRNA levels for Cav-1 were closely
correlated with PKR1 expression levels in ECs and that PKR1
could not mediate insulin uptake in the absence of Cav-1. We
are currently investigating possible crosstalk between PKR1
and insulin signaling via Cav-1 in ECs.
What are the consequences of capillary loss and a lack of
endothelial insulin uptake for peripheral organ function?
Recent reports have suggested that adipose tissue expansion
may be inhibited due to a decrease in the vascularization of
adipose tissue. This leads to lipotoxicity, due to higher levels
of lipolysis and/or ectopic fat deposition.44 Accordingly,
impaired capillary formation in ec-PKR1/ mice results in a
low adipose mass. Lipodystrophies, involving a loss of white
adipose tissue, cause hyperphagia and peripheral insulin
resistance,45 as observed in ec-PKR1 mutant mice. The
impairment of insulin signaling in ec-PKR1/ adipocytes may
also impair the antilipolytic action of insulin, increasing the
rate of FFA release from adipose tissues and preventing the
release of leptin. Hyperphagia is another consequence of
lipodystrophy, due to the lower levels of leptin46 in ec-PKR1/
mice. Consistent with the observed lipodystrophy, inﬂamma-
tion was also detected, in the form of macrophage inﬁltration
and ﬁbrosis in the adipose tissues of ec-PKR1/ mice. Thus,
the adipose tissue of ecPKR1/ mice plays an important role
in the maintenance of systemic insulin sensitivity. The islet
compensatory response to the greater demand for insulin due
to insulin resistance is involved an increase in b-cell size in
Figure 9. Hypertophic b cells in mutant pancreas. A, Immuno-
staining for insulin and b-catenin revealed a higher intensity of the
insulin signal and a larger Langerhans islet area, respectively, in the
mutant pancreas. B, The histograms show the numbers of insulin-
positive cells, together with a quantiﬁcation of the area covered by
these cells (P<0.05). ec-PKR1/ indicates endothelium-speciﬁc
PKR1 knockout mice; L2/2, control mice.
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Figure 10. Rescue of the mutant phenotype by PKR1 gene transfer. A, PKR1 staining showing mutant endothelial cells expressing PKR1 (green)
after infection with adv-PKR1. Scale bar=50 lm. B, The representative illustration and histogram show PECAM-1–positive capillary formation by
ec-PKR1/ adipocytes, for Adv-PKR1 (ec-PKR1+PKR1) – and Adv-control (ec-PKR1-CT) –infected ec-PKR1/ adipocytes (*P<0.05). Scale
bar=10 lm. C, FITC-insulin uptake by PECAM-1–positive ECs (red) from blood vessels derived from ec-PKR1 aortas after infection with Adv-PKR1
or Adv-control. D, Food intake, water intake, and urine volume abnormalities disappeared after the treatment of ec-PKR1/ mice with Adv-PKR1
(n=6). E, The reintroduction of the PKR1 gene rescues metabolic alterations, such as glucose (GTT) and insulin (ITT) tolerance tests, in ec-
PKR1+PKR1 mice, as shown by comparison with ec-PKR1-CT mice at the age of 40 weeks (n=6, *P<0.05). F, Insulin concentrations and creatine
phosphokinase levels in ec-PKR1+PKR1 mice and ec-PKR1-CT mice (n=6). G, Pattern of expression of the genes encoding insulin signaling
molecules (IRS1, IR) and FFA transporters (FABP, FATP1, and FATP4) in ec-PKR1+PKR1 adipocytes and ec-PKR1-CT adipocytes (n=3, P>0.05). H,
The pattern of expression of genes encoding ANF, collagen, and MHC in mutant hearts was normalized by the forced expression of PKR1 (n=3,
*P<0.05). I, Differences in the levels of expression of the genes encoding NCX, nephrin, TGFb, and NaPi in mutant kidneys were abolished by the
treatment of ec-PKR1/ mice with Adv-PKR1 (n=3, *P<0.05). Adv-PKR1 indicates adenovirus carrying prokineticin receptor 1; ANF, atrial
natriuretic factor; EC, endothelial cell; ec-PKR1/, endothelium-speciﬁc PKR1 knockout mice; FFA, free fatty acid; MHC, myosin heavy chain;
NCX-1, transcripts for sodium-calcium; PECAM-1, platelet–endothelial cell adhesion molecule 1; PKR1, prokineticin receptor 1.
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ecPKR1/ mice. The loss of capillaries in the skeletal
muscle, together with limited endothelial insulin uptake and
insulin signaling, may also contribute to abnormal systemic
GTT and ITT results.
The endothelium-speciﬁc ablation of angiogenic factors,
such as ﬁbroblast growth factor47 and platelet-derived growth
factor,48–50 by tie-2 cre/LoxP technology in mice also leads to
heart and kidney disorders. A loss of endothelial ﬁbroblast
growth factor signaling has been shown to induce cardio-
myocyte apoptosis.47 Hence, the loss of ventricular mass in
ec-PKR1/ mice is due to high rates of capillary formation
loss and apoptosis. The remaining viable heart muscle is
subject to greater biomechanical stress, triggering a hyper-
trophic response. The ec-PKR1/ mouse heart displayed EC
dysregulation, capillary refraction, apoptosis, ﬁbrosis, and
ectopic lipid deposition, resulting in an impairment of diastolic
function. Impaired Akt activity in response to insulin is also a
common feature of diabetic cardiomyopathy.51 These pathol-
ogies are considered to be important in the development of
diastolic dysfunction and its progression to systolic dysfunc-
tion and heart failure in diabetic hearts.52
Ectopic lipid accumulation, apoptosis and ﬁbrosis,
impaired insulin signaling, and high levels of phosphate
excretion in urine are implicated in the development of
diabetic nephropathy.53 An antiphosphaturic effect of insulin
has been documented in animals and humans.54 Impaired
insulin signaling, together with low sodium, potassium, and
calcium exchanger levels, may contribute to the high levels of
phosphate excretion in urine of ec-PKR1/ mice. At the age
of 24 weeks, mutant mice displayed high levels of creatinine
clearance and urine volume, potentially contributing to an
increase in water intake. PKR1-null mutant mice have been
shown to display severe structural and functional defects of
their hearts and kidneys, including impaired systolic dysfunc-
tion and proteinuria at older ages.17 The ec-PKR1/ mouse
model provides insight into the common mechanism, endo-
thelial dysfunction, partially underlying the pathological
features of PKR1-null mutant hearts and kidneys.
The ECs lining the vasculature throughout the body are a
massive sink for any adenovirus.34 The rescue of PKR1
expression by adenovirus injection in ec-PKR1/ mice
restored capillary formation and endothelial insulin uptake
and glucose and insulin sensitivity, thereby correcting poly-
phagia, polydipsia, and polyuria. Thus, endothelial PKR1
serves as a positive regulator of insulin sensitivity. The levels
of markers of cardiac and renal disease in ec-PKR1/ mice
were decreased by adenoviral PKR1 treatment. Our data are
consistent with previous ﬁndings showing that PKR1 gene
transfer by adv-PKR1 protects the heart against myocardial
infarction–induced damage.11
In summary, we have shown that endothelial dysfunction
resulting from loss of PKR1 function is the principal mech-
anism for cardiovascular and renal disorders and insulin
resistance in ec-PKR1/ mice. As prokineticin or PKR1 levels
have been shown to be altered in human patients with
abdominal aortic rupture,55 during human end-stage cardiac
Figure 11. Schematic illustration of phenotype of endothelium-speciﬁc PKR1 knockout mice (ec-PKR1/ mice). Loss of prokineticin receptor
1 (PKR1) in endothelial cells leads to endothelial dysfunction characterized by defects in endothelial proliferation rate, capillary formation,
transendothelial insulin uptake, and insulin signaling (eg, nitric oxide synthase [NOS] Akt activity) leading to cardiomyopathy, renal disorders,
lypodystrophy. At the later age, insulin resistance was evident in these mutant mice.
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failure,11 and in obese human adipose tissues (C. G. Nebigil,
unpublished observations) and considering that chronic
administration of prokineticin 2 reduces food intake and
body weight in a mouse model of human obesity,56 our data
indicate a new avenue in the development of preventive and
therapeutic strategies for these disorders, speciﬁcally target-
ing PKR1. Indeed, it is conceivable that the therapeutic
correction of endothelial dysfunction by using PKR1 agonist(s)
can combat insulin resistance, diabetes, and cardiovascular
and renal diseases.
Study Limitations
We have found that ec-PKR1/ mice exhibit capillary
regression and impaired insulin uptake in EC cultures at early
ages (6 and 12 weeks), persisting at later ages (24 and
36 weeks). However, they displayed impaired structure and
function of the heart and kidney at the ages of 12 and
24 weeks and signiﬁcant alteration in GTT and ITT at the ages
of 24 and 36 weeks. Therefore, EC dysfunction was observed
before the occurrence of insulin resistance, indicating that
endothelial dysfunction is not a consequence of insulin
resistance but rather the consequence of a lack of PKR1
signaling within ECs. PKR1 is not expressed in all ECs of the
body; for instance, it is not expressed in liver ECs, and there
were no detectable structural or functional changes of this
organ ec-PKR1/ mice. This further indicates that endothel-
ially expressed PKR1 drives the observed phenotype. ECs are
certainly important in the brain/central nervous system. In
this study, we did not address whether there are alterations in
the ECs of the brain in ec-PKR1/ mice that might be a
possible contributor to some of the changes noted. Our
mutant mice represent a novel model to study the link
between endothelial dysfunction and insulin resistance
accompanied by cardiac and renal defects.
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